Alyeska Investment Group
WINT

Alyeska Investment Group’s Windtree Therapeutics WINT Stock Holding History

Alyeska Investment Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-152
Closed -$98.2K – 691
2023
Q4 		$98.2K Hold
152
– – ﹤0.01% 490
2023
Q3 		$130K Buy
+152
New +$168K ﹤0.01% 467
2020
Q3 		– Hold
0
– – – 606
2020
Q2 		– Hold
0
– – – 590

Other funds holding WINT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return